Tim Martin’s Post

Generative AI is reshaping clinical documentation and regulatory submissions, offering faster, more efficient processes. However, its true success lies in addressing critical challenges: data readiness, optimizing content ecosystems, and eliminating inefficiencies in CSR creation. vanessa de langsdorff of Yseop recently collaborated with John April of Eli Lilly and Company and Inger Ødum Nielsen of Novo Nordisk to publish an article in Applied Clinical Trials Magazine, exploring how organizations are overcoming these challenges and maximizing the return on GenAI investments. 📖 Read the full piece here: https://lnkd.in/eD8i4QiG #GenerativeAI #MedicalWriting #RegulatoryAffairs

NEW! Beyond the benchmark: How Innovative Trial Designs are Transforming Clinical Research: https://ow.ly/Ejkp50UfVMt. Access exclusive insights from the 2024 Annual Global Trends in R&D Report, plus learn why biotechs must focus on innovative strategies, new regulatory frameworks and advanced technologies like AI, to remain at the forefront of clinical development. | In partnership with IQVIA Biotech.

🌟 What role will AI play in healthcare in 2025? Our CEO, Beth Houck, was featured alongside over 50 industry leaders in a recent Citeline's Scrip article by Eleanor Malone and team, sharing perspectives on the transformative impact of artificial intelligence in #biopharma and #healthcare. Beth highlighted how AI is redefining healthcare provider decision-making by: ✅ Reducing the administrative burdens that take time away from patient care. ✅ Supporting informed decision-making for complex, high-acuity cases. ✅ Enhancing workflows, so providers can focus on delivering personalized, hands-on care. At SonarMD, we see AI as a tool to empower—not replace—healthcare providers, ensuring care delivery is both efficient and deeply human. By leveraging AI in chronic GI care, we're paving the way for better outcomes, streamlined care processes, and stronger connections between patients and providers. 📖 Dive into the full article here: https://lnkd.in/gS6_2R_P What do you see as AI's biggest opportunity in healthcare? Let us know in the comments! #ArtificialIntelligence #Biopharma #HealthcareInnovation #SonarMD #ValueBasedCare

With its capability to analyze enormous amounts of data, predictive analytics is reshaping the future of healthcare, enabling hospitals, medical research institutions, and individual healthcare professionals to improve patient care, drug discovery, personalize treatment plans, and more. Read this blog to learn how this transformative technology is revolutionizing the healthcare domain! https://lnkd.in/gkkWDeZp #PredictiveAnalytics #AIInnovation #AIDevelopment #AIbasedApplication #AI #HireAIDevelopers #Quytech #Business #innovation

Read Tom's insights on how 'Artificial intelligence is transforming drug development" and much more within #ICONPLC

How is AI shaping the future of drug development? Tom O’Leary, ICON’s Chief Information Officer, discusses with The Irish Times how AI is revolutionising the industry. From accelerating drug discovery to streamlining clinical trials, AI is optimising processes, enabling data-driven decisions, and delivering patient-centred innovations. ICON’s cutting-edge platforms, such as OneSearch and Cassandra, exemplify how technology is transforming site selection, patient recruitment, and regulatory planning. Click here to learn more in The Irish Times: https://ow.ly/M4N250UtXUw #ClinicalResearch #ArtificialIntelligence #InnovationInHealth

We are excited to announce that Piotr Maślak, Director of Data Intelligence at AstraZeneca, will present his thoughts on the impact of metrics strategy on #ClinicalTrial acceleration at the Disruptive Technology for Clinical Trials Summit Europe in London, UK (28 January 2025). Gain valuable insights from industry leaders like Piotr to optimise your clinical trials by registering online today: https://lnkd.in/eZFC_4QT  #DisruptiveCTEurope  #DataAnalysis #DisruptiveTechnology #AI #DataCollective #Pharma #DigitalTransformation

With its capability to analyze enormous amounts of data, predictive analytics is reshaping the future of healthcare, enabling hospitals, medical research institutions, and individual healthcare professionals to improve patient care, drug discovery, personalize treatment plans, and more. Read this blog to learn how this transformative technology is revolutionizing the healthcare domain! https://lnkd.in/gis575ez #PredictiveAnalytics #AIInnovation #AIDevelopment #AIbasedApplication #AI #HireAIDevelopers #Quytech #Business #innovation

With its capability to analyze enormous amounts of data, predictive analytics is reshaping the future of healthcare, enabling hospitals, medical research institutions, and individual healthcare professionals to improve patient care, drug discovery, personalize treatment plans, and more. Read this blog to learn how this transformative technology is revolutionizing the healthcare domain! https://lnkd.in/gJmekjQd #PredictiveAnalytics #AIInnovation #AIDevelopment #AIbasedApplication #AI #HireAIDevelopers #Quytech #Business #innovation

✨ If you know me, you know how much I love talking about AI in health! ;) That's why I am excited to share that Johnson & Johnson has been featured in Artefact and AI for Health's new report: "Revolutionizing Drug Development with AI: The Future of Clinical Trials". Check out the screenshot below for J&J’s perspective, and don’t forget to explore the full report at this link: https://lnkd.in/exNeVvtr This report takes a deep dive into how AI is reshaping clinical trials—making them faster, more efficient, and more inclusive. It was an honor to represent Johnson & Johnson and contribute to such an important discussion alongside industry leaders like Pfizer, Servier, and innovative tech partners like Deemea, Elaia, Google, Inato, and Klineo.